Metastatic breast cancer: HER2+
From clinical trials to real life data: Current treatment standards and outcomes among HER2+ metastatic breast cancer patients
Date
23 May 2020Session
Metastatic breast cancer: HER2+Presenters
Suzette DelalogeAuthors
S. DelalogeAuthor affiliations
- Breast Oncology Department, Institut Gustave Roussy, 94805 - Villejuif/FR
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
New treatment options for triple positive HER2 metastatic breast cancer
Presenter: Evandro de Azambuja
Session: Metastatic breast cancer: HER2+
Resources:
Slides
Webcast
CNS metastases from HER2+ metastatic breast cancer: Past, present and future
Presenter: Thomas Bachelot
Session: Metastatic breast cancer: HER2+
Resources:
Slides
Webcast
Biomarkers to inform decisions in HER2+ metastatic breast cancer
Presenter: Maria Vittoria Dieci
Session: Metastatic breast cancer: HER2+
Resources:
Slides
Webcast